System Transmission

Top Signal

100#1 JOB

Activity

2181Ripe

+940 today

System

Live1m

Terminal Asset View

stockNASDAQ

ALEC

$2.20-1.35%

Alector Inc

Neutral

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

28Neutral

Live Analysis Active

Synchronizing Data Stream

Establishing multi-vendor link for ALEC

Pipeline Initializing...

System Progress0%

Low Latency Link

Encrypted Port

Company Mission

Alector Inc creates antibody-based drugs to treat neurodegenerative diseases such as Alzheimer's and Parkinson's. Hospitals and patients use these potential therapies to slow disease progression and improve quality of life. The company makes money by partnering with larger pharmaceutical firms and earning payments from clinical trial successes and future drug sales.

ALE

Industry Context

This company operates in the biotechnology sector, focusing on neurodegenerative diseases. It develops therapies using antibodies to target proteins linked to brain disorders. The industry involves high research costs and long development timelines, with success depending on clinical trial outcomes and regulatory approvals.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

70Matrix

Market Momentum

53.9— Holding Steady

Trend Strength

75— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.7x— Normal Volume

Today's Change

-1.35%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing ALEC across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 05:33 AM UTC

As-of As of 2026-03-16T05:17:38.902Z UTC (~15m delay).

Develops antibody-based drugs targeting neurodegenerative diseases like Alzheimer's and Parkinson's, generating revenue through partnerships and clinical trial milestones.

No technical indicators are available, so watch for sector recovery in biotechnology to gauge broader market sentiment and potential momentum shifts.

No price data is available, so monitor if volume exceeds average when data resumes to confirm investor interest and validate any emerging trends.

No social metrics are available, so track industry trends in neurodegenerative research for catalysts like regulatory approvals or competitor advancements.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...